TSXV: ACB
VANCOUVER, July 13, 2017 /CNW/ - Aurora Cannabis Inc. (the
"Company" or "Aurora") (TSXV: ACB) (OTCQX: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) is pleased to
announce that today the Company will be hosting a delegation from
Australia, led by the Honourable
Jaala Pulford, Minister of Agriculture and Minister for Regional
Development for the State of Victoria. The purpose of the
visit to Canada, during which the
delegation will also meet with federal officials in Ottawa, is knowledge transfer with regard to
the regulations governing the medical cannabis sector, as well as
more detailed insight into best practices relating to cultivation,
production and distribution. The visit will provide insights into
the elements that have made the Canadian system, which currently
serves approximately 200,000 patients, so successful.
The Australian delegation will spend a full day with Aurora
executives, visiting both the highly automated 800,000 square foot
Aurora Sky facility now under construction at Edmonton International Airport and the
Company's existing 55,000 square foot production facility in
Mountain View County, Alberta,
which was Canada's first
purpose-built indoor cannabis growing facility.
Also meeting with the Minister today will be the Honourable
Shaye Anderson, Alberta's Minister
of Municipal Affairs and MLA for Leduc-Beaumont, as well as executives representing
two of Aurora's strategic partners: Peter
Crock, CEO of Cann Group Limited, Australia's first licensed cannabis company,
in which Aurora holds a 19.9% stake; and Denis Taschuk, CEO of Radient Technologies Inc.,
an Edmonton concentrates company,
in which Aurora holds a 17% stake.
Australia's Victorian Minister
for Agriculture, Jaala Pulford,
stated, "This visit to Canada
presents an eye-opening opportunity to learn from the best in the
industry. Australia's
medicinal cannabis industry is in its earliest days, and the
knowledge that has been gained in Canada over recent years will help guide us
and take us forward."
Just last month, Victoria
marked a hugely significant milestone in the development of the
medicinal cannabis industry in Australia with the awarding of the first
commercial permit to Melbourne-based company Cann Group.
"Partnerships like the one between Aurora and Cann Group will play
a critical role in establishing best practices and developing
Australia's newest economic
sector. Victoria's
involvement in the medicinal cannabis industry is in its early
phases and we are keen to find out from other, more established
markets what some of the opportunities and challenges are," added
Ms Pulford.
"We are very pleased to be hosting Minister Pulford and her
delegation, and look forward to a day of discussion about the
critical success factors required to establish and rapidly develop
a world-leading medical cannabis system," said Terry Booth, CEO. "We believe the Canadian
cannabis regime under the Access to Cannabis for Medical
Purposes Regulations (ACMPR), as implemented by Health Canada,
has created the most successful, well-developed cannabis system in
the world. The ACMPR has the potential to inspire programs in other
countries, such as Australia,
where medical cannabis programs are in their early stages, and we
are honoured to be part of this knowledge transfer
initiative."
About Aurora
Aurora's wholly-owned subsidiary, Aurora Cannabis Enterprises
Inc., is a licensed producer of medical cannabis pursuant to Health
Canada's Access to Cannabis for Medical Purposes Regulations
("ACMPR"). The Company operates a 55,200 square foot,
state-of-the-art production facility in Mountain View County,
Alberta, and is currently
constructing a second 800,000 square foot production facility,
known as "Aurora Sky", at the Edmonton International Airport, and has
acquired, and is undertaking completion of, a third 40,000 square
foot production facility in Pointe-Claire, Quebec, on Montreal's West Island. In
addition, the company is the cornerstone investor with a 19.9%
stake in Cann Group Limited, the first Australian company licensed
to conduct research on and cultivate medical cannabis, as well as
owns Pedanios, a leading wholesale importer, exporter, and
distributor of medical cannabis in the European Union ("EU"), based
in Germany. Aurora's common shares trade on the TSX-V under
the symbol "ACB".
On behalf of the Board of Directors,
AURORA CANNABIS INC.
Terry Booth, CEO
This news release includes statements containing certain
"forward-looking information" within the meaning of applicable
securities law ("forward-looking statements"). Forward-looking
statements are frequently characterized by words such as "plan",
"continue", "expect", "project", "intend", "believe", "anticipate",
"estimate", "may", "will", "potential", "proposed" and other
similar words, or statements that certain events or conditions
"may" or "will" occur. These statements are only predictions.
Various assumptions were used in drawing the conclusions or making
the projections contained in the forward-looking statements
throughout this news release. Forward-looking statements are based
on the opinions and estimates of management at the date the
statements are made, and are subject to a variety of risks and
uncertainties and other factors that could cause actual events or
results to differ materially from those projected in the
forward-looking statements. The Company is under no obligation, and
expressly disclaims any intention or obligation, to update or
revise any forward-looking statements, whether as a result of new
information, future events or otherwise, except as expressly
required by applicable law.
The TSX Venture Exchange nor its Regulation Services Provider
(as that term is defined in the policies of the TSX Venture
Exchange) accepts responsibility for the adequacy or accuracy of
this release.
SOURCE Aurora Cannabis Inc.